INSIGHTS ON CLINICAL TRIAL PARTNERING

• APAC's Advantage In Oncology Trials: Fast Start, Lower Cost, Global Impact

  Partnering with Southern Star Research provides access to deep regional expertise, operational excellence, and a proven track record of delivering high-quality clinical trials.

• Enhancing Sterility: The Crucial Role Of Isolators In Sterile Fill/Finish

  Isolators provide a controlled and sterile environment during manufacturing. A CDMO that prioritizes quality, sterility, and compliance can help you deliver the highest level of quality and sterility.

• 2025 Clinical Trial Payment Tax Implications Explained

  Flat-rate clinical trial payments are often taxable in the U.S., while reimbursements are not. Unclear tax rules can impact participant trust, site communication, and trial retention.

• The Future Of Oncology Research: Trends And Predictions

  In a clinical trial landscape defined by innovation and empathy, oncology CROs are essential to shaping the future of cancer research.

• Overcoming Unexpected Obstacles In A Phase 1 Study

  1/29/2025

  Discover how the implementation of mobile vision clinics (MVCs) was used to enhance efficiency in a Phase 1 clinical trial.

• A Site's Point Of View Into Study Start-Up

  12/8/2023

  Learn how sites can enhance their ability to meet start-up timelines, positively impacting both operational efficiency and patient outcomes.

• The Importance Of Cognitive And Pharmacodynamic Testing During FIH Trials

  5/9/2025

  Learn how to identify which cognitive and pharmacodynamic tests are required for novel CNS-active drugs and best practices on conducting them during First-In-Human (FIH) trials.

• Working With A Specialty Oncology CRO Versus A Large Generalist CRO

  10/2/2025

  Specialty oncology CROs bridge the gap between traditional CRO operating models and the specialized needs of oncology sponsors by embedding deep oncology expertise across every function.

• How We Used Intelligent Automation to Transform Vendor Selection

  7/2/2025

  Discover how your small biotech can achieve faster timelines, improved cost control, and more strategic, transparent choices with a platform leveraging intelligent automation.